Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treg Characteristics in Giant Cell Arteritis
NCT02857192Completed
- Sponsor
- Centre Hospitalier Universitaire Dijon Bourgogne
- Start
- Oct 2015
- Primary completion
- Mar 2019
- Countries
- 1
01
Overview
Trial (2 arms), sponsored by Centre Hospitalier Universitaire Dijon Bourgogne. Primary endpoint: Percentage of CD39+ Treg among total CD4 TL at 30 months. Started Oct 2015; status: completed.
Beyond the preview
Go deeper on NCT02857192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02857192.